Harvard Bioscience (HBIO) EBT Margin Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 427.00 |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -366.00 |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -113.00 |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 276.00 |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 549.00 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -104.00 |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -1,889.00 |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -3.00 |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -11.00 |
| 10 | Harvard Bioscience | 26.17 Mn | 19.07 Mn | 12.24 Mn | 21,734.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21,734.00 |
| Dec 31, 2025 | -1,590.00 |
| Sep 30, 2025 | 1,493.00 |
| Jun 30, 2025 | 318.00 |
| Mar 31, 2025 | -21,499.00 |
| Dec 31, 2024 | 632.00 |
| Sep 30, 2024 | -1,823.00 |
| Jun 30, 2024 | -691.00 |
| Mar 31, 2024 | -2,232.00 |
| Dec 31, 2023 | -78.00 |
| Sep 30, 2023 | 1,520.00 |
| Jun 30, 2023 | -1,901.00 |
| Mar 31, 2023 | 2,841.00 |
| Dec 31, 2022 | -656.00 |
| Sep 30, 2022 | -1,757.00 |
| Jun 30, 2022 | 1,388.00 |
| Mar 31, 2022 | -2,185.00 |
| Dec 31, 2021 | 519.00 |
| Sep 30, 2021 | 604.00 |
| Jun 30, 2021 | 156.00 |